uBriGene Biosciences International Co.
Davis Kelley is currently a Cell and Gene Therapy Associate PD Scientist at uBriGene Biosciences Inc. since March 2025. Prior experience includes roles as Associate Cell Scientist II and I at AstraZeneca from March 2023 to March 2025, where responsibilities involved maintaining cell sterility in a cGMP environment using aseptic techniques. From June 2020 to August 2021, internships at Johns Hopkins Medicine focused on analyzing skin diseases, contributing to research published in PubMed. Additionally, a Laboratory Assistant position at the University of Maryland involved studying the Rbfox1 gene's impact on Drosophila Melanogaster's innate immune response. Davis Kelley holds a Bachelor of Science in Bioengineering from the University of Maryland, obtained in May 2022.
This person is not in any teams
This person is not in any offices
uBriGene Biosciences International Co.
3 followers
uBriGene Biosciences is a global leader for ATMPs PD, AD and GMP production. With four Centers of Excellence in North America, and Asia Pacific and more than 20 GMP clean room suites, uBriGene supports global CGT and mRNA product development. The uBriGene team of experts has strong expertise in advanced therapy development. The company's manufacturing and analytical platforms are designed to reduce costs, shorten lead times, and boost product yields for our global customers.